학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 730건 | 목록
1~20
Academic Journal
Aamdal, E. ; Skovlund, E. ; Jacobsen, K.D. ; Straume, O. ; Kersten, C. ; Herlofsen, O. ; Karlsen, J. ; Hussain, I. ; Amundsen, A. ; Dalhaug, A. ; Nyakas, M. ; Hagene, K.T. ; Holmsen, K. ; Aamdal, S. ; Kaasa, S. ; Guren, T.K. ; Kyte, J.A.
In ESMO Open October 2022 7(5)
Academic Journal
Vihinen, P; Tervahartiala, T; Sorsa, T; Hansson, J; Bastholt, L; Aamdal, S; Stierner, U; Pyrhonen, S; Syrjanen, K; Lundin, J
CANCER IMMUNOLOGY IMMUNOTHERAPY. 64(2):173-180
Academic Journal
Academic Journal
Prasmickaite, L; Berge, G; Bettum, IJ; Aamdal, S; Hansson, J; Bastholt, L; Oijordsbakken, M; Boye, K; Maelandsmo, GM
CANCER IMMUNOLOGY IMMUNOTHERAPY. 64(6):769-776
Academic Journal
Lung Cancer. 10(1):134-134
Academic Journal
Brandberg, Y; Johansson, H; Aamdal, S; Bastholt, L; Hernberg, M; Stierner, U; von, der Maase H; Hansson, J
ACTA ONCOLOGICA. 52(6):1086-1093
Academic Journal
Lung Cancer. 7:57-57
Academic Journal
EUROPEAN JOURNAL OF CANCER. 48(13):2012-2019
Academic Journal
Schöffski, P. ; Wozniak, A. ; Kasper, B. ; Aamdal, S. ; Leahy, M.G. ; Rutkowski, P. ; Bauer, S. ; Gelderblom, H. ; Italiano, A. ; Lindner, L.H. ; Hennig, I. ; Strauss, S. ; Zakotnik, B. ; Anthoney, A. ; Albiges, L. ; Blay, J.-Y. ; Reichardt, P. ; Sufliarsky, J. ; van der Graaf, W.T.A. ; Debiec-Rychter, M. ; Sciot, R. ; Van Cann, T. ; Marréaud, S. ; Raveloarivahy, T. ; Collette, S. ; Stacchiotti, S.
In Annals of Oncology March 2018 29(3):758-765
Academic Journal
Hamid, O; Schmidt, H; Nissan, A; Ridolfi, L; Aamdal, S; Hansson, J; Guida, M; Hyams, DM; Gomez, H; Bastholt, L
JOURNAL OF TRANSLATIONAL MEDICINE. 9
Academic Journal
Fox, BA; Schendel, DJ; Butterfield, LH; Aamdal, S; Allison, JP; Ascierto, PA; Atkins, MB; Bartunkova, J; Bergmann, L; Berinstein, N
JOURNAL OF TRANSLATIONAL MEDICINE. 9
Academic Journal
Maio M.; Grob J. -J.; Aamdal S.; Bondarenko I.; Robert C.; Thomas L.; Garbe C.; Chiarion-Sileni V.; Testori A.; Chen T. -T.; Tschaika M.; Wolchok J. D.
Journal of Clinical Oncology. 33:1191-1196
Academic Journal
Kaye, S.; Aamdal, S.; Jones, R.; Freyer, G.; Pujade-Lauraine, E.; de Vries, E.G.E.; Barriuso, J.; Sandhu, S.; Tan, D.S.W.; Hartog, V.; Kuenen, B.; Ruijter, R.; Kristensen, G.B.; Nyakas, M.; Barrett, S.; Burke, W.; Pietersma, D.; Stuart, M.; Emeribe, U.; Boven, E.
Br J Cancer
Kaye,S , Aamdal , S , Jones, R, Freyer, G, Pujade-Lauraine, E, de Vries, E G E, Barriuso, J, Sandhu, S , Tan, D S W, Hartog, V, Kuenen, B, Ruijter, R, Kristensen, G B, Nyakas, M, Barrett, S , Burke, W, Pietersma, D, Stuart, M, Emeribe, U & Boven, E 2012, 'Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours', British Journal of Cancer, vol. 106, no. 11, pp. 1728-1734. https://doi.org/10.1038/bjc.2012.158
Kaye,
Academic Journal
Bouwhuis, MG; Suciu, S; Collette, S; Aamdal, S; Kruit, WH; Bastholt, L; Stierner, U; Sales, F; Patel, P; Punt, CJA
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 101(12):869-877
Academic Journal
Aamdal E; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Jacobsen KD; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Straume O; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.; Kersten C; Research Unit, Sørlandet Hospital, Kristiansand, Norway.; Herlofsen O; Department of Oncology, Ålesund Hospital, Ålesund, Norway.; Karlsen J; The Cancer Clinic, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.; Hussain I; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.; Amundsen A; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Dalhaug A; Department of Oncology and Palliative Medicine, Nordland Hospital, Norway.; Nyakas M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Schuster C; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.; Hagene KT; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Holmsen K; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Russnes HG; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Skovlund E; Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.; Kaasa S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Aamdal S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Kyte JA; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Aamdal E; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Inderberg EM; Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Ellingsen EB; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Ultimovacs Allmennaksjeselskap (ASA), Oslo, Norway.; Rasch W; Ultimovacs Allmennaksjeselskap (ASA), Oslo, Norway.; Brunsvig PF; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Aamdal S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Ultimovacs Allmennaksjeselskap (ASA), Oslo, Norway.; Heintz KM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Vodák D; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Nakken S; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Hovig E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.; Nyakas M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Gaudernack G; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Ultimovacs Allmennaksjeselskap (ASA), Oslo, Norway.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Aamdal, S
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어